TOP NEWS: AstraZeneca's Fasenra Gets US FDA Orphan Drug Designation
LONDON (Alliance News) - AstraZeneca PLC on Wednesday said the US Food & Drug Administration has granted Orphan Drug Designation to Fasenra for the treatment of hypereosinophilic is first drug Read More